Endo wants to pay benefits, severance over trustee objection

Chicago, Nov. 8 – Endo International plc is seeking court approval to continue to honor its benefit obligations to its non-insider employees and to continue to make severance payments, when applicable, in spite of a trustee objection.

The company is requesting up to $40 million to be used for long-term incentive plan benefits, consistent with historical practice.

Additionally, the company wants to pay all amounts required under its severance plan, up to $17 million, through the end of 2023.

Endo is offering to consult with the various committees and entities before actually making the payments.

Endo is a Dublin, Ireland-based specialty pharmaceutical company. The Chapter 11 case number is 22-22549.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.